HealthZydus and MSN Labs Launch Generic Riociguat in U.S.
Zydus Lifesciences and MSN Laboratories have launched Riociguat tablets in the U.S., a generic version of Bayer’s Adempas. Approved by the FDA in all five strengths, the drug treats chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Zydus MD Sharvil Patel highlighted this as a milestone reflecting their strong generics pipeline and U.S. market partnerships.
Hindu Business··Hyderabad

